The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience.

Surg Laparosc Endosc Percutan Tech

*Department of Surgery, The University of Texas Health Science Center, Houston ¶Master Center for Minimally Invasive Surgery, Southlake #Ihde Surgical Group, Arlington, TX †Livingston Hospital and Healthcare Services Inc., CAH, Salem, KY ‡Internal Medicine Associates, Merrillville, IN §Mt Graham Regional Medical Center, Safford ##Tempe St Luke's Hospital, Tempe, AZ ∥SurgOne Foregut Institute, Englewood, CO **Allegan Surgical Associates, Allegan, MI ††Munroe Regional Medical Center, Ocala, FL ‡‡Utah County Surgical Associates, Orem, UT §§Crossville Medical Group, PA, Crossville, TN ∥∥Department of Surgery, The George Washington University School of Medicine & Health Sciences, Washington, DC ¶¶Reston Surgical Associates, Reston, VA ***The Surgeons Group of Baton Rouge, Baton Rouge, LA †††EndoGastric Solutions Inc., Redmond, WA.

Published: February 2014

AI Article Synopsis

  • * No major complications were found, with significant reductions in the need for proton pump inhibitors and improvements in symptoms like heartburn and regurgitation among patients.
  • * Overall, TIF was concluded to be a safe and effective treatment option for selected patients suffering from chronic GERD.

Article Abstract

Purpose: This study aimed to assess the impact of transoral incisionless fundoplication (TIF) on patients with chronic gastroesophageal reflux disease (GERD) at 12-month follow-up.

Methods: Clinical outcomes of 100 consecutive patients with chronic GERD who underwent TIF between January 2010 and February 2011 were analyzed.

Results: There were no major complications reported. Esophageal acid exposure was normalized in 14/27 (52%) of patients who underwent 12-month pH testing. Seventy-four percent of all patients were off proton pump inhibitors versus 92% on daily proton pump inhibitors before TIF, P<0.001. Daily bothersome heartburn and regurgitation symptoms were eliminated in 66/85 (78%) and 48/58 (83%) of patients. Median reflux symptom index score was reduced from 20 (0 to 41) to 5 (0 to 44), P<0.001. Two patients reported de novo dysphagia and 1 patient reported bloating (scores 0 to 3). Six patients underwent revision; 5 laparoscopic Nissen fundoplication and 1 TIF.

Conclusions: TIF provided a safe and effective therapeutic option for carefully selected patients with chronic GERD.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLE.0b013e3182a2b05cDOI Listing

Publication Analysis

Top Keywords

transoral incisionless
8
incisionless fundoplication
8
chronic gerd
8
patients chronic
8
proton pump
8
pump inhibitors
8
patients
5
effects transoral
4
fundoplication chronic
4
gerd patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!